ECS Botanics Holdings Ltd Logo

ECS Botanics Holdings Ltd

ECS.AX

(1.5)
Stock Price

0,02 AUD

6.05% ROA

7.69% ROE

10.86x PER

Market Cap.

23.193.893,00 AUD

0.85% DER

0% Yield

9.94% NPM

ECS Botanics Holdings Ltd Stock Analysis

ECS Botanics Holdings Ltd Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

ECS Botanics Holdings Ltd Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (2%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 PBV

The stock's PBV ratio (1.07x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

3 Revenue Growth

Over the past three years, this company's revenue has consistently grown, demonstrating a positive financial trend that makes it an appealing choice.

4 Net Profit Growth

Over the last three years, this company has consistently achieved net profit growth, indicating a favorable financial performance and making it an attractive investment option.

5 Assets Growth

With a track record of continuous revenue growth in the last three years, this company offers a promising investment opportunity

6 ROE

The stock's ROE indicates a negative return (-5.85%) on shareholders' equity, suggesting poor financial performance.

7 ROA

The stock's ROA (-5.7%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

8 Graham Number

Based on the Graham number, this company's stock price appears to be higher than its intrinsic value, signaling a potentially unfavorable investment choice.

9 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

10 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (0) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

ECS Botanics Holdings Ltd Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

ECS Botanics Holdings Ltd Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

ECS Botanics Holdings Ltd Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

ECS Botanics Holdings Ltd Revenue
Year Revenue Growth
1989 0
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 3.272.870 100%
2002 2.500.000 -30.91%
2003 1.780.284 -40.43%
2004 269.832 -559.77%
2005 0 0%
2006 7.647 100%
2007 141.309 94.59%
2008 4.414.694 96.8%
2009 5.285.567 16.48%
2010 21.740.527 75.69%
2011 59.553.000 63.49%
2012 56.521.000 -5.36%
2013 50.887.000 -11.07%
2014 35.982.000 -41.42%
2015 17.505.960 -105.54%
2016 67.890 -25685.77%
2017 0 0%
2018 0 0%
2019 15.813 100%
2020 836.760 98.11%
2020 836.760 0%
2021 1.246.619 32.88%
2022 13.841.848 90.99%
2022 5.298.588 -161.24%
2023 15.388.929 65.57%
2024 34.984.872 56.01%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

ECS Botanics Holdings Ltd Research and Development Expenses
Year Research and Development Expenses Growth
1989 0
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 2.045.585 100%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2020 0 0%
2021 74.874 100%
2022 109.216 31.44%
2022 119.664 8.73%
2023 21.559 -455.05%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

ECS Botanics Holdings Ltd General and Administrative Expenses
Year General and Administrative Expenses Growth
1989 0
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 1.862.346 100%
2002 1.456.000 -27.91%
2003 1.420.581 -2.49%
2004 1.014.974 -39.96%
2005 209.013 -385.6%
2006 1.128.555 81.48%
2007 1.122.472 -0.54%
2008 3.335.379 66.35%
2009 2.989.069 -11.59%
2010 7.098.461 57.89%
2011 22.290.000 68.15%
2012 21.123.000 -5.52%
2013 21.234.000 0.52%
2014 18.160.000 -16.93%
2015 8.832.362 -105.61%
2016 191.195 -4519.56%
2017 123.959 -54.24%
2018 96.980 -27.82%
2019 233.383 58.45%
2020 1.268.605 81.6%
2020 952.889 -33.13%
2021 1.045.292 8.84%
2022 1.263.560 17.27%
2022 1.435.431 11.97%
2023 1.802.800 20.38%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

ECS Botanics Holdings Ltd EBITDA
Year EBITDA Growth
1989 -122.000
1990 36.000 438.89%
1991 -412.000 108.74%
1992 426.000 196.71%
1993 -236.000 280.51%
1994 58.000 506.9%
1995 -869.000 106.67%
1996 -921.737 5.72%
1997 -2.630.116 64.95%
1998 -2.585.738 -1.72%
1999 -3.929.308 34.19%
2000 -4.835.000 18.73%
2001 -12.152.000 60.21%
2002 -4.747.000 -155.99%
2003 -3.078.104 -54.22%
2004 -400.138 -669.26%
2005 -1.235.190 67.61%
2006 -1.888.015 34.58%
2007 -2.198.841 14.14%
2008 -3.712.946 40.78%
2009 -1.879.071 -97.59%
2010 -953.718 -97.03%
2011 -1.775.000 46.27%
2012 801.000 321.6%
2013 -195.000 510.77%
2014 -871.000 77.61%
2015 9.743.157 108.94%
2016 -350.918 2876.48%
2017 -263.896 -32.98%
2018 -240.355 -9.79%
2019 -856.780 71.95%
2020 -4.547.092 81.16%
2020 -4.506.110 -0.91%
2021 -5.296.360 14.92%
2022 -1.262.796 -319.42%
2022 -1.100.770 -14.72%
2023 -1.969.370 44.11%
2024 4.020.600 148.98%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

ECS Botanics Holdings Ltd Gross Profit
Year Gross Profit Growth
1989 0
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 495.294 100%
2002 1.236.000 59.93%
2003 455.059 -171.61%
2004 175.539 -159.24%
2005 0 0%
2006 7.647 100%
2007 66.799 88.55%
2008 1.900.332 96.48%
2009 2.089.112 9.04%
2010 8.077.193 74.14%
2011 22.306.000 63.79%
2012 22.700.000 1.74%
2013 21.282.000 -6.66%
2014 16.618.000 -28.07%
2015 8.264.105 -101.09%
2016 -786 1051512.85%
2017 0 0%
2018 0 0%
2019 -469.824 100%
2020 140.219 435.06%
2020 -591.668 123.7%
2021 -3.593.167 83.53%
2022 2.492.352 244.17%
2022 120.285 -1972.04%
2023 -1.101.391 110.92%
2024 12.937.108 108.51%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

ECS Botanics Holdings Ltd Net Profit
Year Net Profit Growth
1989 504.000
1990 -156.000 423.08%
1991 262.000 159.54%
1992 71.000 -269.01%
1993 199.000 64.32%
1994 160.000 -24.38%
1995 -208.000 176.92%
1996 335 62189.55%
1997 -2.630.000 100.01%
1998 -597.000 -340.54%
1999 -3.504.000 82.96%
2000 -4.865.000 27.98%
2001 -12.188.000 60.08%
2002 -4.882.000 -149.65%
2003 -3.201.120 -52.51%
2004 -460.644 -594.92%
2005 -1.479.068 68.86%
2006 -1.699.286 12.96%
2007 -2.270.019 25.14%
2008 -9.732.152 76.68%
2009 -7.949.328 -22.43%
2010 -1.725.663 -360.65%
2011 -19.899.000 91.33%
2012 -7.790.000 -155.44%
2013 -7.392.000 -5.38%
2014 -3.007.000 -145.83%
2015 8.818.825 134.1%
2016 -351.288 2610.43%
2017 -263.548 -33.29%
2018 -218.712 -20.5%
2019 -846.764 74.17%
2020 -4.569.470 81.47%
2020 -4.569.470 0%
2021 -4.335.572 -5.39%
2022 -2.731.544 -58.72%
2022 -1.115.436 -144.89%
2023 228.380 588.41%
2024 2.967.704 92.3%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

ECS Botanics Holdings Ltd Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1989 0
1990 0 0%
1991 0 0%
1992 73 100%
1993 204 64.71%
1994 158 -29.11%
1995 -187 184.49%
1996 0 0%
1997 -1.194 100%
1998 -265 -350.57%
1999 -1.730 84.67%
2000 -1.976 12.5%
2001 -6.222 68.24%
2002 -1.072 -480.32%
2003 -467 -129.55%
2004 -6 -9240%
2005 -9 37.5%
2006 -7 -33.33%
2007 -3 -100%
2008 -5 25%
2009 -3 -100%
2010 0 0%
2011 -1 100%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

ECS Botanics Holdings Ltd Free Cashflow
Year Free Cashflow Growth
1989 0
1990 0 0%
1991 0 0%
1992 -36.000 100%
1993 -216.000 83.33%
1994 -371.000 41.78%
1995 -1.454.000 74.48%
1996 -1.572.910 7.56%
1997 -191.000 -723.51%
1998 -136.000 -40.44%
1999 -40.000 -240%
2000 -3.226.000 98.76%
2001 -2.900.000 -11.24%
2002 -71.000 -3984.51%
2003 -53.306 -33.19%
2004 -3.175 -1578.93%
2005 -70.384 95.49%
2006 -17.647 -298.84%
2007 -199.392 91.15%
2008 -385.700 48.3%
2009 0 0%
2010 -288.995 100%
2011 -627.000 53.91%
2012 -341.000 -83.87%
2013 -1.336.000 74.48%
2014 -518.000 -157.92%
2015 -255.654 -102.62%
2016 -384.894 33.58%
2017 -283.846 -35.6%
2018 -216.963 -30.83%
2019 -591.029 63.29%
2020 -4.380.047 86.51%
2021 -5.706.412 23.24%
2022 -7.632.387 25.23%
2022 -1.111.197 -586.86%
2023 -2.896.526 61.64%
2024 -2.948.063 1.75%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

ECS Botanics Holdings Ltd Operating Cashflow
Year Operating Cashflow Growth
1989 0
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 -384.894 100%
2017 -283.846 -35.6%
2018 -216.963 -30.83%
2019 -561.029 61.33%
2020 -2.925.617 80.82%
2021 -2.264.102 -29.22%
2022 -4.712.681 51.96%
2022 49.288 9661.52%
2023 402.679 87.76%
2024 -1.908.826 121.1%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

ECS Botanics Holdings Ltd Capital Expenditure
Year Capital Expenditure Growth
1989 0
1990 0 0%
1991 0 0%
1992 36.000 100%
1993 216.000 83.33%
1994 371.000 41.78%
1995 1.454.000 74.48%
1996 1.572.910 7.56%
1997 191.000 -723.51%
1998 136.000 -40.44%
1999 40.000 -240%
2000 3.226.000 98.76%
2001 2.900.000 -11.24%
2002 71.000 -3984.51%
2003 53.306 -33.19%
2004 3.175 -1578.93%
2005 70.384 95.49%
2006 17.647 -298.84%
2007 199.392 91.15%
2008 385.700 48.3%
2009 0 0%
2010 288.995 100%
2011 627.000 53.91%
2012 341.000 -83.87%
2013 1.336.000 74.48%
2014 518.000 -157.92%
2015 255.654 -102.62%
2016 0 0%
2017 0 0%
2018 0 0%
2019 30.000 100%
2020 1.454.430 97.94%
2021 3.442.310 57.75%
2022 2.919.706 -17.9%
2022 1.160.485 -151.59%
2023 3.299.205 64.83%
2024 1.039.237 -217.46%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

ECS Botanics Holdings Ltd Equity
Year Equity Growth
1989 3.871.000
1990 3.425.000 -13.02%
1991 4.037.000 15.16%
1992 4.340.000 6.98%
1993 4.293.000 -1.09%
1994 5.396.000 20.44%
1995 3.012.000 -79.15%
1996 8.176.253 63.16%
1997 5.546.137 -47.42%
1998 5.003.389 -10.85%
1999 3.809.929 -31.32%
2000 5.727.418 33.48%
2001 696.023 -722.88%
2002 1.897.858 63.33%
2003 -404.286 569.43%
2004 848.968 147.62%
2005 1.500.269 43.41%
2006 182.844 -720.52%
2007 4.599.278 96.02%
2008 11.485.632 59.96%
2009 6.175.271 -85.99%
2010 28.591.876 78.4%
2011 11.848.000 -141.32%
2012 7.134.000 -66.08%
2013 -283.000 2620.85%
2014 -1.994.000 85.81%
2015 671.514 396.94%
2016 319.744 -110.02%
2017 407.196 21.48%
2018 188.484 -116.04%
2019 -127.847 247.43%
2020 5.034.736 102.54%
2021 17.089.532 70.54%
2022 22.169.674 22.91%
2023 22.202.194 0.15%
2024 28.212.526 21.3%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

ECS Botanics Holdings Ltd Assets
Year Assets Growth
1989 4.010.000
1990 3.469.000 -15.6%
1991 4.178.000 16.97%
1992 4.478.000 6.7%
1993 4.445.000 -0.74%
1994 5.892.000 24.56%
1995 3.198.000 -84.24%
1996 8.728.643 63.36%
1997 5.918.312 -47.49%
1998 13.819.945 57.18%
1999 12.835.213 -7.67%
2000 17.325.538 25.92%
2001 12.130.640 -42.82%
2002 3.285.508 -269.22%
2003 2.054.093 -59.95%
2004 1.069.137 -92.13%
2005 1.818.190 41.2%
2006 436.830 -316.22%
2007 5.618.723 92.23%
2008 13.561.337 58.57%
2009 7.534.698 -79.99%
2010 49.862.097 84.89%
2011 33.763.000 -47.68%
2012 25.907.000 -30.32%
2013 20.210.000 -28.19%
2014 20.357.000 0.72%
2015 739.748 -2651.88%
2016 370.484 -99.67%
2017 424.277 12.68%
2018 212.717 -99.46%
2019 7.115.176 97.01%
2020 5.466.772 -30.15%
2021 20.005.932 72.67%
2022 23.821.616 16.02%
2023 26.127.460 8.83%
2024 32.881.228 20.54%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

ECS Botanics Holdings Ltd Liabilities
Year Liabilities Growth
1989 139.000
1990 44.000 -215.91%
1991 141.000 68.79%
1992 138.000 -2.17%
1993 152.000 9.21%
1994 496.000 69.35%
1995 186.000 -166.67%
1996 552.390 66.33%
1997 372.175 -48.42%
1998 8.816.556 95.78%
1999 9.025.284 2.31%
2000 11.598.120 22.18%
2001 11.434.617 -1.43%
2002 1.387.650 -724.03%
2003 2.458.379 43.55%
2004 220.169 -1016.59%
2005 317.921 30.75%
2006 253.986 -25.17%
2007 1.019.445 75.09%
2008 2.075.705 50.89%
2009 1.359.427 -52.69%
2010 21.270.221 93.61%
2011 21.915.000 2.94%
2012 18.773.000 -16.74%
2013 20.493.000 8.39%
2014 22.351.000 8.31%
2015 68.234 -32656.4%
2016 50.740 -34.48%
2017 17.081 -197.06%
2018 24.233 29.51%
2019 7.243.023 99.67%
2020 432.036 -1576.49%
2021 2.916.400 85.19%
2022 1.651.942 -76.54%
2023 3.925.266 57.92%
2024 4.668.702 15.92%

ECS Botanics Holdings Ltd Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.02
Net Income per Share
0
Price to Earning Ratio
10.86x
Price To Sales Ratio
1.16x
POCF Ratio
-14.54
PFCF Ratio
-6.81
Price to Book Ratio
0.77
EV to Sales
1.05
EV Over EBITDA
-33.16
EV to Operating CashFlow
-14.17
EV to FreeCashFlow
-6.19
Earnings Yield
0.09
FreeCashFlow Yield
-0.15
Market Cap
0,02 Bil.
Enterprise Value
0,02 Bil.
Graham Number
0.03
Graham NetNet
0.01

Income Statement Metrics

Net Income per Share
0
Income Quality
-0.75
ROE
0.08
Return On Assets
0.06
Return On Capital Employed
-0.07
Net Income per EBT
1.04
EBT Per Ebit
-0.98
Ebit per Revenue
-0.1
Effective Tax Rate
-0.04

Margins

Sales, General, & Administrative to Revenue
0.05
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.08
Operating Profit Margin
-0.1
Pretax Profit Margin
0.1
Net Profit Margin
0.1

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0
Free CashFlow per Share
-0
Capex to Operating CashFlow
-1.29
Capex to Revenue
0.1
Capex to Depreciation
1.44
Return on Invested Capital
-0.07
Return on Tangible Assets
0.06
Days Sales Outstanding
32.56
Days Payables Outstanding
42.86
Days of Inventory on Hand
259.47
Receivables Turnover
11.21
Payables Turnover
8.52
Inventory Turnover
1.41
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,02
Tangible Book Value per Share
0.02
Shareholders Equity per Share
0.02
Interest Debt per Share
0
Debt to Equity
0.01
Debt to Assets
0.01
Net Debt to EBITDA
3.36
Current Ratio
5.07
Tangible Asset Value
0,03 Bil.
Net Current Asset Value
0,02 Bil.
Invested Capital
24346735
Working Capital
0,02 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
11708932
Debt to Market Cap
0.01

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

ECS Botanics Holdings Ltd Dividends
Year Dividends Growth

ECS Botanics Holdings Ltd Profile

About ECS Botanics Holdings Ltd

ECS Botanics Holdings Ltd engages in the cultivation, manufacture, and sale of medicinal cannabis products. It also retails hemp wellness and food products; and engages in the agriculture business. The company is based in Launceston, Australia.

CEO
Ms. Nan-Maree Schoerie Dip Ch
Employee
220
Address
94 Green Rises Road
Launceston, 7302

ECS Botanics Holdings Ltd Executives & BODs

ECS Botanics Holdings Ltd Executives & BODs
# Name Age
1 Mr. Michael Clark
Head of European Operations
70
2 Mr. Nicholas Thomas
Chief Operating Officer
70
3 Ms. Nan-Maree Schoerie Dip Chem
MD & Executive Director
70
4 Mr. Arthur Sun
Chief Financial Officer
70
5 Mr. Mauro Piccini
Company Secretary
70

ECS Botanics Holdings Ltd Competitors